H.R. 1730, Cancer Drug Parity Act, regarding all provisions.

S. 741, Cancer Drug Parity Act,regarding all provisions.

H.R. 2279, Safe Step Act, issues relating to Step Therapy / Fail First.

HR 965 / S. 340, CREATES Act, provisions regarding REMS.

S. 2543, Prescription Drug Pricing Reduction Act of 2019, provisions regarding Medicare Part D / Part B. 

S. 2546, Safe Step Act, provisions regarding Step Therapy / Fail First.

Reimbursement for and patient access to Chimeric Antigen Receptor (CAR) T-cell therapies.

Issues relating to Medicare Reimbursement and Medicare Part D / Part B.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CELGENE CORPORATION
86 Morris Ave, Summit, NJ, 07901, US
GREG CHESMORE STEPHEN RUBRIGHT ALANNA TEMME MATTHEW SCHUMAKER